Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Sep 10, 2018
- Poly (ADP-ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: A Drug Class Review.
Ringley J Tanner et al. P & T : a peer-reviewed journal for formulary management 2018 Sep (9) 549-556 - Finding Pediatric Cancer Genomic Data through PGDI
NCI, September 2018 - Unraveling the Mystery of What Gives Exceptional Responders Their Superpower
J Cavallo, ASCO Post, August 2018 - Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang Xuehong et al. PLoS medicine 2018 Sep 15(9) e1002644 - BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
Gross Amy L et al. JAMA 2018 Aug 320(6) 597-598 - Broad Genomic Testing in NSCLC: No Survival Benefit?
et al. Cancer discovery 2018 Aug - Cancer genetics, precision prevention and a call to action.
Turnbull Clare et al. Nature genetics 2018 Sep 50(9) 1212-1218 - Family History and Cancer
CDC Division of Cancer Control and Prevention, 2018 - Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma.
Gleeson Ferga C et al. Current treatment options in gastroenterology 2018 Sep - Genomic Prostate Score, PI-RADSv2, and Progression in Men with Prostate Cancer on Active Surveillance.
Kornberg Zachary et al. The Journal of urology 2018 Sep
No hay comentarios:
Publicar un comentario